ESSILOR (EPA:EL) 2009 Registration Document Field
Transparency directive : regulatory news
31/03/2010 18:00
Click here to download pdf version
Regulatory Information
2009 Registration Document Filed
Charenton-le-Pont (March 31, 2010 - 6:00 pm) - The 2009 Essilor Registration
Document was filed with the Autorité des Marchés Financiers (AMF) on March
30, 2009 under the number D.10-0189.
The Registration Document includes:
a) The Annual Financial Report, with:
The parent company financial statements;
The consolidated financial statements;
A management report containing information in compliance with articles
L.225-100, L.225-100-3, L.225-11 (§ 2) and L.225-100-2 of the French
Commercial Code;
A statement by the persons responsible for the Registration Document;
The report of the Auditors on the parent company and consolidated
financial statements;
Information concerning Auditors' fees;
The Annual Information Document.
b) The Chairman's report on corporate governance and internal control.
c) The description of the share buyback program.
It is available to the public free of charge, as provided for in applicable
legislation, and may be viewed on Essilor's website www.essilor.com.
The world leader in ophthalmic optical products, Essilor International
researches, develops, manufactures and markets around the world a wide range of
lenses to correct myopia, hyperopia, presbyopia and astigmatism. Its flagship
brands are Varilux(r), Crizal(r), Essilor(r), Definity(r) and Xperio(TM). Based
in France, the company reported consolidated revenue of EUR3.2 billion in 2009,
with 34,700 employees and operations in 100 countries.
For more information, please visit www.essilor.com.
The Essilor share trades on the NYSE Euronext Paris market and is included in
the CAC 40 index. Codes and symbols: ISIN: FR FR0000121667; Reuters: ESSI.PA;
Bloomberg: EI:FP.
Investor Relations and Financial Communications
Phone: +33 (0)1 49 77 42 16
www.essilor.com